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Differential microsatellite instability (MSI) in tumour epithelial and stromal compartments has not been well examined for colorectal
cancers. Using laser-captured microdissection, separate specimens of these compartments of 40 sporadic colorectal cancers were
sampled and MSI was tested with four markers. To examine the relation between the MSI phenotype in the stroma and other genetic
events and histopathological features, p53 and K-ras gene mutations were analysed, and the expression of p53, hMLH1, and hMSH2
protein was determined by immunohistochemistry. Microsatellite instability positive results were obtained for both epithelium (34%)
and stromal tissue (41%). While MSI in epithelium correlated with differentiation and Dukes’ stage, that in stroma demonstrated an
inverse relation, being particularly frequent in well-differentiated adenocarcinomas (54%) and Dukes’ A lesions (55%). Further, a
significant inverse correlation between p53 protein overexpression in the epithelium and MSI in the stroma was found (P¼0.02475).
The results suggest an alternative pathway of carcinogenesis involving stromal genetic instability in the development of colorectal
cancers.
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Interactions between epithelial and mesenchymal cells in the
various organs play important roles in their development (Marsh
and Trier, 1974; Shekhar et al, 2001), differentiation (Camps et al,
1990; Hom et al, 1998) and growth (Camps et al, 1990; Hom et al,
1998). However, the contribution of stromal cells to the generation
and progression of epithelial neoplasia has not been thoroughly
investigated. Although genetic alterations are frequently observed
in many benign and malignant epithelial tumours in the form of
microsatellite instability (MSI) (Michael-Robinson et al, 2001;
Ward et al, 2001), the possibility of genetic abnormalities in the
background microenvironment of these tumours has generally not
been addressed properly. However, recent findings indicate that
loss of heterozygosity (LOH) may be frequent in mammary
stromal tissue in breast cancer patients (Moinfar et al, 2000). In
one series of sporadic colorectal cancers, it was found that
approximately 15% of tumours demonstrated MSI (Michael-
Robinson et al, 2001). Since data on MSI in stroma of colorectum
have hitherto not been published, to our knowledge, here we
investigated this point with reference to clinicopathological
features of colorectal cancers, using laser-captured microdissec-
tion. A recent study showed high p53 gene mutation loads in
ulcerative colitis with an inflammatory microenvironment predis-
posed to colorectal carcinoma (Hussain et al, 2000; Yoshida et al,
2003). To test the hypothesis that genetic instability in the p53
locus stage might be a key early event in tumorigenesis, with
change in the stroma possible influencing epithelial tumorigenesis,
microsatellite markers D17S796 (Gyapay et al, 1994), TP53 and
D17S786 (Gyapay et al, 1994), located in the short arm of
chromosome 17 within 4cM proximity to the p53 gene (17p13),
and D17S579 (17q21) (Anderson et al, 1993) in the long arm of the
chromosome 17 were analysed here in a series of sporadic
colorectal cancers.
MATERIALS AND METHODS
Samples and preparation
In total, 40 surgically resected sporadic colorectal adenocarcino-
mas from patients, 24–89-years old, undergoing treatment at
Kitasato University Hospital and Kitasato University East Hospital,
were randomly selected. Histological typing was performed
according to the criteria of the Japanese Society for Cancer of
the Colon and Rectum (Jinnai, 1983) and also Dukes’ classification.
On surgical removal, tissues were immediately frozen with
liquid nitrogen in OCT compound for storage at  801C. Frozen
sections 10 (10mm thick) were fixed in 70% alcohol and stained
with Mayer’s haematoxylin. Neoplastic epithelial and adjacent
stromal tissues in the lamina propria were carefully microdissected
with a laser-captured microdissection system (LM200, Arcturus,
Mountain View, CA, USA) to avoid contamination (Figure 1A).
Tissues from whole sections, including both epithelial and stromal
elements (mixed), were also manually dissected. Tumour tissues
with strong inflammatory cell infiltration were excluded from
study. Likewise, normal mucosa from the colorectum of the same
patients was sampled and processed as an internal control. Tissues
were lysed in sodium dodecyl sulphate-lysis buffer with proteinase
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ethanol precipitation method.
Microsatellite analysis
The polymerase chain reaction (PCR) was performed for four
microsatellite markers, D17S796, TP53 (forward: 50-ACTGC-
CACTCCTTGCCCCATTC-30, reverse: 50-CACCTCGGGCTGAA-
TAGTATCCCT-30), D17S786, and D17S579, selected for analysing
allelic instability in chromosome 17. Microdissected DNA (5–
10ng) was amplified with a Rapid Cycler (Idaho Technology,
Idaho falls, ID, USA) and Takara Ex Taq DNA polymerase
(Takara, Kyoto, Japan) under conditions as follows: 941C for 3min
as the initial step, 35 cycles of 0s at 941C, 0s at an appropriate
temperature for each marker amplification, 6s at 741C, and a final
step of 741C for 3min. The PCR products were fractionated by
3.6% polyacrylamide gel electrophoresis, fixed with 10% forma-
mide and visualised using a Silver Stain Plus Kit (Bio-Rad,
Hercules, CA, USA).
Results for normal tissues were considered informative when
two or three (because some samples were insufficient for PCR
amplification even if the experiment was repeated) of three
samples, including epithelium, stroma, and mixed tissue DNA
from each case, exhibited identical banding patterns. In pairs with
informative normal tissue, sufficient PCR amplification of tumour
tissues was considered as informative and MSI was defined as
either a marked alteration in repeat length or as a new discrete
band above or below the expected allele (Figure 1B). We referred to
a previous report to judge whether the samples were informative
(Luttges et al, 2001). Cases for which pairs of samples were
informative for two of four markers were defined as informative
and those showing MSI positivity (MSIþ) for at least one marker
were considered as MSIþ.
Immunohistochemistry and p53 and K-ras gene analysis
To analyse p53, hMLH1, and hMSH2 protein expression and
for assessment of p53 and K-ras gene mutations, tissues were
fixed routinely in 10% buffered formalin and embedded in
paraffin. Serial sections (3mm thick) were applied for haematox-
ylin and eosin staining, immunohistochemistry, and mutation
analyses.
Immunohistochemical staining was performed with monoclonal
anti-p53 (DO7,   300 dilution, Novocastras Lab., Newcastle, UK),
monoclonal anti-hMLH1 (Clone; G168-15,   200 dilution, BD
PharMingen, San Diego, CA, USA) and monoclonal anti-hMSH2
(Clone; G219-1129,   500 dilution, BD PharMingen) antibodies,
using the standard labelled streptavidin–biotin–peroxidase com-
plex method described in our previous report (Yamashita et al,
2001). The amounts of positive cells were expressed as the
percentage of the total number of epithelial cells and assigned to
one of three categories for p53 : þþ, 450%; þ, 0.5–50%;  ,
o0.5% (Figure 3I–K), for hMLH1 and hMSH2 : þþ, 450%;
þ, 10–50%;  , o10% (Figure 3A–F). We also examined the
expression of hMLH1 and hMSH2 proteins in stromal cells, with
classification into : þþ, strong staining; þ, focal staining;  ,
negative staining. Definite nuclear staining of adjacent non-
neoplastic epithelial and stroma cells or lymphocytes served as
internal positive controls.
p53 and K-ras gene mutations were analysed by the PCR-single
strand conformation polymorphism (SSCP) method described in
our previous report (Yamashita et al, 2001). Mutations were
detected as abnormally shifted bands.
Statistics
Differences for each category of clinicopathological features, with
reference to MSI in the epithelium and stroma were examined
using the Fisher’ s exact and w
2 tests.
RESULTS
MSI status
Microsatellite instability was frequently detected in epithelial and
stromal areas of sporadic colorectal cancers (Table 1). Of the 40
colorectal cancers studied, 13 out of 38 informative cases (34%)
were MSIþ for one or more of the markers in tumour epithelium,
16 out of 39 cases (41%) in adjacent stromal areas, and nine of 40
(23%) in mixed tissue. MSIþ for two or more markers was found
in three cases in the epithelium and two in stroma. While MSI was
slightly more common in the stroma than epithelium, the
difference did not reach significance (Table 1). For each
component, only three cases had MSI in both epithelium and
stroma for the same markers (two for TP53 and one for D17S796),
suggesting appropriate microdissection without contamination.
Others showed MSI specific to the epithelium alone, stroma alone,
epithelium and mixed tissue (Figure 1B; D17S786), or stroma and
mixed tissue. All the tumours with MSI in mixed tissue also
demonstrated MSI in epithelium and stroma. A comparison of MSI
frequency for each marker between the epithelium and stroma
revealed stromal MSIþ to be less frequent (1/36¼3%) than
epithelial MSIþ (6/37¼16%) for D17S786 (P¼0.0512) (Table 1).
With D17S796, MSI was more often found in the stroma (8/
33¼24%) than in the epithelium (4/36¼11%), without signifi-
cance (Table 1). No differences were found for D17S579 and TP53.
Concerning the low MSI frequency for mixed tissue as compared
with the epithelium or stroma alone, MSI DNA might disturb the
positivity with MSI-PCR due to lowered sensitivity.
A
B
Before After
Epithelium
Epithelium
Stroma
Stroma Mixed Epithelium Stroma Mixed
NT NT NT NT NT NT
TP53 D17S786
D17S579 D17S796
Figure 1 (A) Example of microdissection of epithelial cells and adjacent
stromal cells from a single histologic section. Original magnification,   100,
(B) Representive data from microsatellite analysis of sporadic colorectal
cancers. Arrows indicate shifted bands reflecting microsatellite instability.
N¼normal mucosa; T¼tumour tissue.
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status
Histopathological and molecular features of the sporadic
colorectal cancers are detailed in Table 2. MSI frequencies differed
between epithelium and stroma in well-differentiated
(P-value¼0.0393) and poorly differentiated (P-value¼0.0510)
(Figure 2A) adenocarcinomas. Stromal MSIþ was more often
detected in well-differentiated adenocarcinomas (7/13¼54%)
than in poorly differentiated cancers (1/10¼10%)
(P-value¼0.0286), whereas the frequency of epithelial MSIþ
correlated with progression (Figure 2A). With analysis of Dukes’
stage, although there was a tendency for an inverse relation with
stromal MSIþ (Figure 2B), it did not reach significance
(P-value¼0.4807). In contrast, epithelial MSIþ showed signifi-
cant variation with the Dukes’ stage (P-value¼0.0277) (Figure 2B).
A significant correlation was also detected between epithelial
MSIþ and stromal MSIþ and Dukes’ stage (P-value¼0.0455). It
is notable that in stage A lesions, stromal MSIþ (6/11¼55%) was
more frequent than epithelial MSIþ (0/10¼0%) (P-
value¼0.0057) (Figure 2B).
MSI status, p53 gene mutations, and p53 protein
overexpression
A significant inverse correlation between p53 protein overexpres-
sion in epithelium and MSI in stroma was found (7/10¼70% in
‘þ’ cases vs 6/22¼27% in ‘þþ’ cases) (P-value¼0.02475)
(Figure 2C). p53 gene mutations were detected in 15 out of 40
(38%) tumours with no significant differences observed with
reference to epithelial and stromal MSI (Table 2).
Table 2 MSI findings for the epithelium and stroma, with reference to tumour features
MSI+ cases /informative cases MSI+ cases/informative cases
Variable Total cases Epithelium Stroma P-value Mixed tissue
Location
Right side 14 6/14 (43%) 7/14 (50%) 0.3549 4/14 (29%)
Left side 26 7/24 (29%) 9/25 (36%) 0.1388 5/26 (19%)
Differentiation
Well 14 2/13 (15%) 7/13 (54%) 0.0393* 2/14 (14%)
Moderate 16 6/15 (40%) 8/16 (50%) 0.5761 5/16 (31%)
Poor 10 5/10 (50%) 1/10 (10%) 0.0510** 2/10 (20%)
Dukes’ stage
A 11 0/10 (0%) 6/11 (55%) 0.0057* 1/11 (9%)
B 12 6/12 (50%) 5/12 (42%) 0.6820 4/12 (33%)
C 17 7/16 (44%) 5/16 (31%) 0.4652 4/17 (24%)
p53 mutation
+ 15 4/13 (31%) 5/14 (36%) 0.7854 4/15 (27%)
  25 9/25 (36%) 11/25 (44%) 0.5637 5/25 (20%)
K-ras mutation
+ 12 5/11 (45%) 6/11 (55%) 0.6698 4/12 (33%)
  28 8/27 (30%) 10/27 (37%) 0.6307 5/28 (18%)
p53 protein
  7 1/7 (14%) 3/7 (43%) 0.5594 1/7 (14%)
+ 10 3/10 (30%) 7/10 (70%) 0.0943
** 3/10 (30%)
++ 23 9/21 (43%) 6/22 (27%) 0.5127 5/23 (22%)
hMLH1 protein
  2/4 (50%)
a 1/1 (100%)
b
+ 0/6 (0%) 12/30 (40%)
++ 11/27 (40%) 3/7 (43%)
hMSH2 protein
  0/1 (0%)
a 0/0 (0%)
b
+ 3/9 (33%) 16/35 (46%)
++ 10/25 (40%) 0/2 (50%)
Significance was determined by the w
2 test and Fisher’s exact test (epithelium vs stroma).’MSI+ cases’ refer to cases that showed MSI+ for at least one marker. *Po0.05,
**Po0.1.
an ¼ The cases of hMLH1 or hMSH2 protein expression in epithelial cells.
bn ¼ The cases of hMLH1 or hMSH2 protein expression in stromal cells.
Table 1 MSI frequencies for each microsatellite marker
MSI+ samples/informative samples MSI+ samples/informative samples
Marker Epithelium Stroma P-value Mixed tissue
D17S796 4/36 (11%) 8/33 (24%) 0.1506 1/38 (3%)
TP 53 6/35 (17%) 6/35 (17%) 0.9999 5/37 (14%)
D17S786 6/37 (16%) 1/36 (3%) 0.0512 3/40 (8%)
D17S579 4/36 (11%) 3/37 (8%) 0.6631 4/39 (10%)
Total 13/38 (34%) 16/39 (41%) 0.5372 9/40 (23%)
Significance was determined by the w
2 test (epithelium vs stroma). Total refers to informative cases that showed MSI+ for at least one marker.
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K-ras gene mutations were detected in 12 out of 40 (30%) tumours
with no significant differences observed with reference to epithelial
and stromal MSI (Table 2).
hMLH1 and hMSH2 protein expression in epithelial and
stromal MSI
Losses of hMLH1 and hMSH2 expression were detected in 10% (4/
40) and 3% (1/40) of cases in the epithelium and 3% (1/40) and 0%
(0/40) in the stroma, respectively. No significant correlations
between hMLH1 and hMSH2 protein expression in epithelial or
stromal cells and epithelial MSIþ or stromal MSIþ were found
(Table 2) (P-value not shown).
DISCUSSION
Regarding interactions between the epithelium and stroma, several
hypotheses have been proposed to explain fibroblast-promoting
effects on tumour growth. Most of the intercellular material, the
extracellular matrix (ECM) molecules that are required for tumour
growth and progression, is produced by stromal cells (Noel et al,
1998). It has been demonstrated that neoplastic breast stroma drives
alteration in gene expression as compared with normal tissue
(Leygue et al, 1998). In fact, it is generally believed that the epithe-
lium is the neoplastic element in most tumours and that altered gene
expression in stroma occurs as the secondary reaction. However, the
recent finding of frequent genetic changes in mammary stromal
tissue in breast cancer patients (Moinfar et al, 2000), and the
demonstration that inflammation-associated stroma promotes
conversion of colonic adenoma cells to adenocarcinoma cells in
nude mice (Okada et al, 2000) suggest a more complex scenario.
Our present study showed that MSI in stromal and epithelial
elements can occur independently in sporadic colorectal cancers,
in line with the previous findings for breast carcinomas (Kurose
et al, 2001). Further, while MSI in the epithelium tended to
correlate with differentiation and the Dukes’ stage, the inverse was
the case for MSI in stroma. These interesting results strongly
suggest that there are alternative mechanisms involving stromal
MSI operating in colorectal carcinogenesis and progression.
According to Young et al, methylation of CpG island occurs both
in the epithelium and stroma (Young et al, 2001). Stromal MSI
presented in this study might be due to the methylation of
mismatch repair enzymes in stromal cells, although the identifica-
tion of the enzyme remains unclear. Previously, it was shown that
high-level MSI (MSI-H) tumours are more likely to be right sided
than their low-level MSI (MSI-L) or MSI stable counterparts
(Michael-Robinson et al, 2001; Ward et al, 2001). In the present
study, while MSI frequencies in both the epithelium and stroma
were high in right-side (43, 50%) as compared to left-side lesions
(29, 36%), the difference did not reach statistical significance. This
might be due to relatively small numbers of examined cases or
inclusion of both MSI-L and MSI-H results in our analysis.
Additionally, we examined the expression of DNA mismatch repair
enzymes, hMLH1 and hMSH2 protein, in epithelial and stromal
cells, respectively, as the MSI-H phenotype has been suggested to
be of importance for the DNA mismatch repair system in sporadic
colorectal cancers (Dietmaier et al, 1997; Ward et al, 2001). In the
present study, epithelial MSIþ for two or more markers was
found in three cases, two of which showed loss of hMLH1 protein
expression. In stroma, MSIþ for two or more markers was found
in two cases, one of which showed loss of MLH1 in stromal cells
(Figure 3G and H). Although we have not used the standard
markers that were recommended for MSI analysis on the basis of a
National Cancer Institute Workshop (Boland et al, 1998), the
results of hMLH1 and hMSH2 protein expression provide support
for the validity of our study of MSI in epithelial and stromal cells.
NCI-recommended standard markers are two mononucleotide
repeat markers and three dinucleotide markers, but all of the
markers we used in this study are dinucleotide repeat markers
((CA)n repeat). Therefore, it is difficult to compare MSI-H entity
with our MSIþ for two or more markers. Additionally,
discordance of the loss of hMLH1 or hMSH2 and our MSIþ
tumours could occur in the present study.
Although no significant links were found between MSI and p53
or K-ras gene mutations, MSI in the epithelium, but not stroma,
tended to correlate positively with p53 protein overexpression.
Recently, Kapiteijn et al. (2001) reported that p53 gene mutation
corresponds more often to p53 overexpression in left- than in
right-sided tumours, suggesting that mechanisms of oncogenesis
may differ between the two cases. This is in line with our results for
a greater prevalence of p53 overexpression with p53 gene
mutations in left-sided tumours (9/11, 81%), than in those found
on the right side (1/4, 25%) (P¼0.0390, data not shown).
Furthermore, we found a difference in the relation between p53
mutations and stromal MSI (stromal MSIþ/p53 mutation, 3/11
(27%) in the left-side; 3/4 (75%) in the right-side, P¼0.0952).
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Figure 2 Data for MSI with reference to tumour features.
E¼epithelium; S¼stroma; M¼mixed tissue. *Po0.01;
#Po0.05.
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suggest a relation of p53 mutation to stromal MSIþ.
From the available data, contrary to the general belief that
abnormalities in stroma occur as reactions to epithelial tumour
cells, we propose the hypothesis that an alternative pathway may
exist, with stromal genetic instability influencing epithelial cells in
carcinogenesis.
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